In the September 10, 2024, issue of JACC, Dr. Valentin Fuster highlights groundbreaking research on lipid exposure in early adulthood and its link to later cardiovascular events, the importance of early and serial assessments in cardiogenic shock, and the impact of triglyceride levels on cardiovascular outcomes with alirocumab. He also discusses the association between postnatal opioid exposure and neurodevelopmental outcomes in infants undergoing cardiac surgery, alongside a brief update on the long-term benefits of Mercantor in obstructive hypertrophic cardiomyopathy.